Crossmark

Comparative Analysis of the Therapeutic Effects of Amniotic Membrane and Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Type 2 Diabetes

Crossref DOI link: https://doi.org/10.1007/s12015-021-10320-w

Published Online: 2022-01-11

Published Print: 2022-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Zhifeng https://orcid.org/0000-0001-8470-888X
Li, Haisen

Fang, Jingmeng

Wang, Xiaoyu

Dai, Shuhang

Cao, Wei

Guo, Yinhong

Li, Zhe

Zhu, Hao
Funding

Funding for this research was provided by:

SNC and Tongji University (SNC2018007)
License Information

Text and Data Mining valid from 2022-01-11

Version of Record valid from 2022-01-11
More Information

Article History

Accepted: 16 December 2021

First Online: 11 January 2022

Declarations

:

: The authors declare that there are no conflicts of interest.

: The care and use of human AMMSCs and UCMSCs were approved by the Tenth People’s Hospital of Tongji University. The donor has signed the informed consent.All animal experiments were reviewed and approved by the Laboratory Animal Care and Use Committee of Tongji University.

: Informed consent was obtained from all individual participants included in the study.

: All participants have approved this article to be published.

Document is current

Any future updates will be listed below